Search research articles
Contact Us
Filters
Showing results (191-200 of 198) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 198 results.
Cancer Discovery
|
December 9, 2024
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer
Lisa N Chesner, Fanny Polesso, Julie N Graff, et al.
Nature
|
February 15, 2018
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan, Shannon J Turley, Dorothee Nickles, et al.
The Lancet. Oncology
|
March 6, 2025
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation
Zachary S Morris, Sandra Demaria, Arta M Monjazeb, et al.
Cancer Research
|
October 17, 2022
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
Martin Sjöström, Shuang G Zhao, Samuel Levy, et al.
Cell
|
July 24, 2018
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
David A Quigley, Ha X Dang, Shuang G Zhao, et al.
Cell
|
October 20, 2018
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
David A Quigley, Ha X Dang, Shuang G Zhao, et al.
Nature Medicine
|
January 6, 2025
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial
Juanita Lopez, Thomas Powles, Fadi Braiteh, et al.
Nature Genetics
|
July 15, 2020
The DNA methylation landscape of advanced prostate cancer
Shuang G Zhao, William S Chen, Haolong Li, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 198) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 198 results.
Cancer Discovery
|
December 9, 2024
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer
Lisa N Chesner, Fanny Polesso, Julie N Graff, et al.
Nature
|
February 15, 2018
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan, Shannon J Turley, Dorothee Nickles, et al.
The Lancet. Oncology
|
March 6, 2025
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation
Zachary S Morris, Sandra Demaria, Arta M Monjazeb, et al.
Cancer Research
|
October 17, 2022
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
Martin Sjöström, Shuang G Zhao, Samuel Levy, et al.
Cell
|
July 24, 2018
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
David A Quigley, Ha X Dang, Shuang G Zhao, et al.
Cell
|
October 20, 2018
Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
David A Quigley, Ha X Dang, Shuang G Zhao, et al.
Nature Medicine
|
January 6, 2025
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial
Juanita Lopez, Thomas Powles, Fadi Braiteh, et al.
Nature Genetics
|
July 15, 2020
The DNA methylation landscape of advanced prostate cancer
Shuang G Zhao, William S Chen, Haolong Li, et al.
Page
of 20